(Q33397763)

26 July 2017

0 references

Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials (English)

1 reference

26 July 2017

0 references

1 reference

1 reference

1 reference

7

Edward Mills

1 reference

26 July 2017

Dugald Seely

1

1 reference

26 July 2017

Ping Wu

2

1 reference

26 July 2017

Heidi Fritz

3

1 reference

26 July 2017

Deborah A Kennedy

4

1 reference

26 July 2017

Teresa Tsui

5

1 reference

26 July 2017

Andrew J E Seely

6

1 reference

26 July 2017

publication date

21 October 2011

1 reference

Integrative Cancer Therapies

26 July 2017

published in

1 reference

26 July 2017

volume

11

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

293-303

1 reference

Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Melatonin: from basic research to cancer treatment clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Therapeutic actions of melatonin in cancer: possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Night work and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Night shift work and the risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Carcinogenicity of shift-work, painting, and fire-fighting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Night work and breast cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Melatonin in cancer management: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

The statistical basis of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Is there a role for melatonin in supportive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

Melatonin and melatonergic drugs on sleep: possible mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735411425484

21 January 2018

Identifiers

DOI

10.1177/1534735411425484

1 reference

26 July 2017

1 reference